Evid Science leverages artificial intelligence to provide insights into Patient Reported Outcomes (PROs) for clinical trials, focusing on enhancing patient-centered care. The company operates in the life sciences sector, serving pharmaceutical companies, clinical researchers, and healthcare providers. Evid Science's business model revolves around offering AI-powered analytics and data solutions that help clients understand and optimize PROs, which are crucial for assessing the impact of treatments from the patient's perspective. By analyzing vast amounts of data, the company helps identify key symptoms and instruments associated with specific diseases, enabling more effective and personalized treatment strategies. Revenue is generated through subscription-based services and customized analytics solutions tailored to the needs of their clients.

Keywords: AI, Patient Reported Outcomes, clinical trials, life sciences, pharmaceutical, healthcare, analytics, data solutions, personalized treatment, subscription services.